Cargando…
Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice
The co-occurrence of colorectal cancer (CRC) and diabetes mellitus along with inflammation and dismicrobism has been frequently reported. Several studies shed light on the antioncogenic potential of metformin on colorectal carcinogenesis. This study aimed to demonstrate that metformin in association...
Autores principales: | Al Kattar, Sahar, Jurjus, Rosalyn, Pinon, Aline, Leger, David Yannick, Jurjus, Abdo, Boukarim, Chawki, Diab-Assaf, Mona, Liagre, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408863/ https://www.ncbi.nlm.nih.gov/pubmed/32664279 http://dx.doi.org/10.3390/cancers12071857 |
Ejemplares similares
-
Involvement of autophagy in diosgenin-induced megakaryocyte differentiation in human erythroleukemia cells
por: Diab, Dima, et al.
Publicado: (2021) -
A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019) -
Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019) -
Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links
por: Jurjus, Abdo, et al.
Publicado: (2015) -
Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
por: Dandash, Fatima, et al.
Publicado: (2021)